---
title: "ROSEN，一家备受信赖的领先律师事务所，敦促纽尔真检测公司投资者在证券集体诉讼的重要截止日期之前获取法律咨询"
description: "纽约，2025 年 8 月 9 日（GLOBE NEWSWIRE）——为什么：罗森律师事务所，一家全球投资者权益律师事务所，提醒在 2023 年 1 月 5 日至 2025 年 6 月 3 日期间（“诉讼期间”）购买 Neogen Corporation（NEOG）普通股的投资者，注意 2025 年 9 月 16 日的重要首席原告"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/252338188.md"
published_at: "2025-08-09T14:09:45.000Z"
---

# ROSEN，一家备受信赖的领先律师事务所，敦促纽尔真检测公司投资者在证券集体诉讼的重要截止日期之前获取法律咨询

> 纽约，2025 年 8 月 9 日（GLOBE NEWSWIRE）——为什么：罗森律师事务所，一家全球投资者权益律师事务所，提醒在 2023 年 1 月 5 日至 2025 年 6 月 3 日期间（“诉讼期间”）购买 Neogen Corporation（NEOG）普通股的投资者，注意 2025 年 9 月 16 日的重要首席原告

NEW YORK, Aug. 09, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neogen Corporation NEOG between January 5, 2023 and June 3, 2025, inclusive ( the "Class Period" ) , of the important September 16, 2025 lead plaintiff ...

### Related Stocks

- [NEOG.US - 纽尔真检测](https://longbridge.com/zh-CN/quote/NEOG.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Neogen CEO Mikheal Nassif Reports Acquisition of Common Shares | Mikheal Nassif, CEO of Neogen Corporation, announced the acquisition of common shares of the company. The full filing is | [Link](https://longbridge.com/zh-CN/news/274560850.md) |
| Animal Health Firm Neogen Initiates Recall Of Vials Over Microbial Contamination | Neogen Corporation has initiated a voluntary recall of all unexpired lots of its Neogen Vet HYCOAT Hyaluronate Sodium St | [Link](https://longbridge.com/zh-CN/news/274186608.md) |
| Neogen CEO Mikheal Nassif Acquires Common Shares | Mikheal Nassif, CEO and Director of Neogen Corporation, has acquired common shares of the company. The full filing is av | [Link](https://longbridge.com/zh-CN/news/272846760.md) |
| Neogen beats Q2 revenue estimates, raises guidance | Neogen's Q2 revenue fell 2.8% but exceeded analyst expectations, with adjusted net income and EBITDA also beating estima | [Link](https://longbridge.com/zh-CN/news/271929303.md) |
| Neogen Non-GAAP EPS of $0.10 beats by $0.03, revenue of $224.7M beats by $16.32M | Neogen Non-GAAP EPS of $0.10 beats by $0.03, revenue of $224.7M beats by $16.32M | [Link](https://longbridge.com/zh-CN/news/271929891.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。